Adverse Effects

Contributing journals to this collection:
JAMA & Archives Journals

Citations 41-50 of 1622 total displayed.

Past content

Original Contributions
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

Christoph U. Correll; Peter Manu; Vladimir Olshanskiy; Barbara Napolitano; John M. Kane; Anil K. Malhotra
JAMA 2009; 302: 1765-1773. [Abstract] [Full text] [PDF] [ eTables ]  

Editorials
Implications of Marked Weight Gain Associated With Atypical Antipsychotic Medications in Children and Adolescents

Christopher K. Varley; Jon McClellan
JAMA 2009; 302: 1811-1812. [Extract] [Full text] [PDF]  

Editorials
Adverse Events in Randomized Trials: Neglected, Restricted, Distorted, and Silenced

John P. A. Ioannidis
Arch Intern Med 2009; 169: 1737-1739. [Extract] [Full text] [PDF]  

Commentaries
Going Off-label Without Venturing Off-Course: Evidence and Ethical Off-label Prescribing

Emily A. Largent; Franklin G. Miller; Steven D. Pearson
Arch Intern Med 2009; 169: 1745-1747. [Extract] [Full text] [PDF]  

Original Investigations
Reporting of Safety Results in Published Reports of Randomized Controlled Trials

Isabelle Pitrou; Isabelle Boutron; Nizar Ahmad; Philippe Ravaud
Arch Intern Med 2009; 169: 1756-1761. [Abstract] [Full text] [PDF] [ eAppendix ]  

Original Investigations
Evaluating the Incremental Benefits of Raising High-Density Lipoprotein Cholesterol Levels During Lipid Therapy After Adjustment for the Reductions in Other Blood Lipid Levels

Steven A. Grover; Mohammed Kaouache; Lawrence Joseph; Philip Barter; Jean Davignon
Arch Intern Med 2009; 169: 1775-1780. [Abstract] [Full text] [PDF]  

Medical News & Perspectives
Despite Health Claims by Manufacturers, Little Oversight for Homeopathic Products

Bridget M. Kuehn
JAMA 2009; 302: 1631-1634. [Extract] [Full text] [PDF]  

Editorials
Can the Food and Drug Administration Ensure That Our Pharmaceuticals Are Safely Manufactured?

William K. Hubbard
Arch Intern Med 2009; 169: 1655-1656. [Extract] [Full text] [PDF]  

Original Investigations
Glucocorticoid Use and Risk of Atrial Fibrillation or Flutter: A Population-Based, Case-Control Study

Christian Fynbo Christiansen; Steffen Christensen; Frank Mehnert; Steven R. Cummings; Roland D. Chapurlat; Henrik Toft Sørensen
Arch Intern Med 2009; 169: 1677-1683. [Abstract] [Full text] [PDF] [ eAppendix ]  

Original Investigations
New-Onset Breast Tenderness After Initiation of Estrogen Plus Progestin Therapy and Breast Cancer Risk

Carolyn J. Crandall; Aaron K. Aragaki; Rowan T. Chlebowski; Anne McTiernan; Garnet Anderson; Susan L. Hendrix; Barbara B. Cochrane; Lewis H. Kuller; Jane A. Cauley
Arch Intern Med 2009; 169: 1684-1691. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163